In particular, neuronal pentraxin 2 is described as the earliest biomarker to become detectably abnormal, as compared to other CSF markers, in presymptomatic carriers of gene mutations related to frontotemporal dementia.44 Here, NPTX2 is linked to frontotemporal dementia.